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2010-2011 Influenza Season 
Week 43 ending October 30, 2010 
All data are preliminary and may change as more reports are received. 
 
Synopsis: During week 43 (October 24-30, 2010), influenza activity remained low in the United 
States. 
o Twenty-five (1.4%) specimens tested by U.S. World Health Organization (WHO) and 
National Respiratory and Enteric Virus Surveillance System (NREVSS) collaborating 
laboratories and reported to CDC/Influenza Division were positive for influenza. 
o The proportion of deaths attributed to pneumonia and influenza (P&I) was below the 
epidemic threshold.  
o One influenza-associated pediatric death was reported. This death was associated with an 
influenza A virus for which the subtype was undetermined and occurred during the 2009-10 
season.  
o The proportion of outpatient visits for influenza-like illness (ILI) was below the national 
baseline. All 10 regions reported ILI below region-specific baseline levels; one state 
experienced low ILI activity, 48 states experienced minimal ILI activity, and one state had 
insufficient data. 
o Geographic spread of influenza in the U.S. Virgin Islands was reported as regional; Guam 
and one state reported local influenza activity; the District of Columbia, Puerto Rico, and 28 
states reported sporadic activity; and 21 states reported no influenza activity. 
 
National and Regional Summary of Select Surveillance Components 
 Data for current week Data cumulative since October 3, 2010 (Week 40) 
HHS 
Surveillance 
Regions* 
Out-
patient 
ILI† 
% 
positive 
for flu‡ 
Number of  
jurisdictions 
reporting 
regional or 
widespread 
activity§ 
A (H3) 2009 A (H1N1) 
A 
(Subtyping not 
performed) 
B Pediatric Deaths 
Nation Normal 1.4% 1 of 54 83 30 128 90 0 
Region 1 Normal 1.5% 0 of 6 4 1 0 1 0 
Region 2 Normal 0.9% 1 of 4 1 0 6 1 0 
Region 3 Normal 0.3% 0 of 6 5 1 0 1 0 
Region 4 Normal 7.6% 0 of 8 20 7 93 66 0 
Region 5 Normal 2.2% 0 of 6 12 2 0 0 0 
Region 6 Normal 2.0% 0 of 5 14 0 6 6 0 
Region 7 Normal 0.3% 0 of 4 1 0 1 0 0 
Region 8 Normal 1.6% 0 of 6 8 3 11 1 0 
Region 9 Normal 4.7% 0 of 5 17 16 10 13 0 
Region 10 Normal 0.4% 0 of 4 1 0 1 1 0 
 
*HHS regions (Region 1 CT, ME, MA, NH, RI, VT; Region 2: NJ, NY, Puerto Rico, U.S. Virgin Islands; Region 3: DE, DC, MD, PA, VA, WV; Region 4: AL, FL, GA, KY, MS, NC, 
SC, TN; Region 5: IL, IN, MI, MN, OH, WI; Region 6: AR, LA, NM, OK, TX; Region 7: IA, KS, MO, NE; Region 8: CO, MT, ND, SD, UT, WY; Region 9: AZ, CA, Guam, HI, NV; 
and Region 10: AK, ID, OR, WA). 
† Elevated means the % of visits for ILI is at or above the national or region-specific baseline. 
‡ National data are for current week; regional data are for the most recent three weeks. 
§ Includes all 50 states, the District of Columbia, Guam, Puerto Rico, and the U.S. Virgin Islands. 
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U.S. Virologic Surveillance: WHO and NREVSS collaborating laboratories located in all 50 states 
and Washington D.C. report to CDC the number of respiratory specimens tested for influenza and 
the number positive by influenza type and subtype. The results of tests performed during the 
current week are summarized in the table below. 
 
 Week 43 
No. of specimens tested 1,853 
No. of positive specimens (%) 25 (1.4%) 
Positive specimens by type/subtype  
Influenza A 16 (64.0%) 
          A (2009 H1N1)   2 (12.5%)  
          A (subtyping not performed)          7 (43.8%)
          A (H3)                7 (43.8%)  
Influenza B 9 (36.0%) 
 
 
Influenza Positive Tests Reported to CDC by U.S. WHO/NREVSS 
Collaborating Laboratories, National Summary, 2010-11 Season 
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Aggregate Hospitalization and Death Reporting Activity (AHDRA): This system tracks weekly 
counts of laboratory-confirmed influenza-associated hospitalizations and deaths and was 
implemented on August 30, 2009, during the 2009 pandemic, and ended on April 4, 2010. AHDRA 
surveillance during the 2010-11 season is being continued on a voluntary basis and 17 jurisdictions 
reported during week 43. From October 3-30, 2010, 75 laboratory-confirmed influenza associated 
hospitalizations and two laboratory-confirmed influenza associated deaths were reported to CDC.  
Weekly Laboratory-Confirmed Influenza-Associated Hospitalizations and 
Deaths, National Summary, 2010-11 Season 
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Antigenic Characterization:  CDC has antigenically characterized one 2009 influenza A (H1N1) 
and one influenza B collected by U.S. laboratories since October 1, 2010. 
 
2009 Influenza A (H1N1) [1] 
• This virus was characterized as A/California/7/2009-like, the 2009 influenza A 
(H1N1) component of the 2010-11 influenza vaccine for the Northern Hemisphere. 
 
Influenza B [1] 
 This virus belongs to the B/Victoria lineage of viruses and was characterized as 
B/Brisbane/60/2008-like, the recommended influenza B component for the 2010-11 
Northern Hemisphere influenza vaccine. 
Antiviral Resistance: Testing of 2009 influenza A (H1N1), influenza A (H3N2), and influenza B 
virus isolates for resistance to neuraminidase inhibitors (oseltamivir and zanamivir) is performed at 
CDC using a functional assay. Additional 2009 influenza A (H1N1) clinical samples are tested for a 
single known mutation in the neuraminidase protein of the virus that confers oseltamivir resistance 
(H275Y). The data summarized below combine the results of both test methods and includes 
samples that were tested as part of routine surveillance purposes; it does not include diagnostic 
testing specifically done because of clinical suspicion of antiviral resistance. 
High levels of resistance to the adamantanes (amantadine and rimantadine) persist among 2009 
influenza A (H1N1) and A (H3N2) viruses (the adamantanes are not effective against influenza B 
viruses) circulating globally. As a result of the sustained high levels of resistance, data from 
adamantane resistance testing are not presented weekly in the table below.     
Neuraminidase Inhibitor Resistance Testing Results  
on Samples Collected Since October 1, 2010. 
 Viruses tested (n) 
Resistant 
Viruses, 
Number (%) 
Viruses 
tested (n) 
Resistant 
Viruses, 
Number (%) 
Oseltamivir Zanamivir 
Seasonal 
Influenza A 
(H1N1) 
0 0 (0.0) 0 0 (0.0) 
Influenza A 
(H3N2) 0 0 (0.0) 0 0 (0.0) 
Influenza B 1 0 (0.0) 1 0 (0.0) 
2009 
Influenza A 
(H1N1) 
5 0 (0.0) 4 0 (0.0) 
 
 
To prevent the spread of antiviral resistant virus strains, CDC reminds clinicians and the public of 
the need to continue hand and cough hygiene measures for the duration of any symptoms of 
influenza, even while taking antiviral medications. Additional information on antiviral 
recommendations for treatment and chemoprophylaxis of influenza virus infection is available at 
http://www.cdc.gov/flu/antivirals/index.htm.    
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Pneumonia and Influenza (P&I) Mortality Surveillance: During week 43, 6.4% of all deaths 
reported through the 122-Cities Mortality Reporting System were due to P&I. This percentage was 
below the epidemic threshold of 6.8% for week 43. 
 
Pneumonia and Influenza Mortality for 122 U.S. Cities 
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Influenza-Associated Pediatric Mortality: One influenza-associated pediatric death was reported 
to CDC during week 43 (Georgia). This death was associated with an influenza A virus for which 
the subtype was not determined. This death occurred during the 2009-10 influenza season and 
brings the total number of reported pediatric deaths occurring during that season to 282. No 
influenza-associated pediatric deaths occurring during the 2010-11 season have been reported to 
CDC. 
 
Number of Influenza-Associated Pediatric Deaths by Week of Death: 
2007-08 season to present 
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Influenza-Associated Hospitalizations: The Influenza Hospitalization Network (FluSurv-NET) 
conducts surveillance for population-based, laboratory-confirmed influenza related hospitalizations 
in children (persons less than 18 years) and adults. The network covers over 80 counties in the 10 
Emerging Infections Program (EIP) states (CA, CO, CT, GA, MD, MN, NM, NY, OR, and TN) and 
six additional states (ID, MI, OH, OK, RI and UT). FluSurv-NET estimated hospitalization rates will 
be updated every two weeks starting later this season. 
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Outpatient Illness Surveillance: Nationwide during week 43, 1.3% of patient visits reported 
through the U.S. Outpatient Influenza-like Illness Surveillance Network (ILINet) were due to 
influenza-like illness (ILI). This percentage is below the national baseline of 2.5%. 
 
Percentage of Visits for Influenza-like Illness (ILI) Reported by  
the U.S. Outpatient Influenza-like Illness Surveillance Network (ILINet), 
Weekly National Summary, September 30, 2007 – October 30, 2010 
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On a regional level, the percentage of outpatient visits for ILI ranged from 0.3% to 1.8% during 
week 43. All 10 regions reported a proportion of outpatient visits for ILI below their region-specific 
baseline levels.   
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Region 6 - AR, LA, NM, OK, TX
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Region 2 - NJ, NY, USVI
0
2
4
6
8
10
20
08
40
20
08
50
20
09
10
20
09
20
20
09
30
20
09
40
20
09
50
20
10
10
20
10
20
20
10
30
20
10
40
Week
%
 o
f V
is
its
 fo
r I
LI
  
Region 3 - DE, DC, MD, PA, VA, WV
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Region 4 - AL, FL, GA, KY, MS, NC, SC, TN
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Region 5 - IL, IN, MI, MN, OH, WI
0
2
4
6
8
10
20
08
40
20
08
50
20
09
10
20
09
20
20
09
30
20
09
40
20
09
50
20
10
10
20
10
20
20
10
30
20
10
40
Week
%
 o
f V
is
its
 fo
r I
LI
  
Region 7 - IA, KS, MO, NE
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ILINet Activity Indicator Map: Data collected in ILINet are used to produce a measure of ILI 
activity* by state. Activity levels are based on the percent of outpatient visits in a state due to ILI 
and are compared to the average percent of ILI visits that occur during spring and fall weeks with 
little or no influenza virus circulation. Activity levels range from minimal, which would correspond to 
ILI activity from outpatient clinics being below the average, to high, which would correspond to ILI 
activity from outpatient clinics being much higher than the average. 
 
During week 43, the following ILI activity levels were experienced: 
 One state (West Virginia) experienced low ILI activity 
 New York City, the District of Columbia and 48 states were experiencing minimal ILI activity 
(Alabama, Alaska, Arizona, Arkansas, California, Colorado, Connecticut, Delaware, Florida, 
Georgia, Hawaii, Idaho, Illinois, Indiana, Iowa, Kansas, Louisiana, Maine, Maryland, 
Massachusetts, Michigan, Minnesota, Mississippi, Missouri, Montana, Nebraska, Nevada, 
New Hampshire, New Jersey, New Mexico, New York, North Carolina, North Dakota, Ohio, 
Oklahoma, Oregon, Pennsylvania, Rhode Island, South Carolina, South Dakota, 
Tennessee, Texas, Utah, Vermont, Virginia, Washington, Wisconsin, and Wyoming). 
 One state (Kentucky) had insufficient data. 
 
Interactive web tool available at: http://gis.cdc.gov/grasp/fluview/main.html 
 
*This map uses the proportion of outpatient visits to health care providers for influenza-like illness to measure the ILI activity level within a 
state. It does not, however, measure the extent of geographic spread of flu within a state. Therefore, outbreaks occurring in a single city 
could cause the state to display high activity levels. 
Data collected in ILINet may disproportionately represent certain populations within a state, and therefore, may not accurately depict the 
full picture of influenza activity for the whole state. 
Data displayed in this map are based on data collected in ILINet, whereas the State and Territorial flu activity map are based on reports 
from state and territorial epidemiologists. The data presented in this map is preliminary and may change as more data is received. 
Differences in the data presented by CDC and state health departments likely represent differing levels of data completeness with data 
presented by the state likely being the more complete.  
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Geographic Spread of Influenza as Assessed by State and Territorial Epidemiologists: The 
influenza activity reported by state and territorial epidemiologists indicates geographic spread of 
influenza viruses, but does not measure the severity of influenza activity. 
 
During week 43, the following influenza activity was reported: 
 Regional influenza activity was reported by the U.S. Virgin Islands. 
 Local influenza activity was reported by Guam and one state (Hawaii). 
 Sporadic influenza activity was reported by the District of Columbia, Puerto Rico, and 28 
states (Alabama, Arizona, California, Colorado, Connecticut, Florida, Georgia, Illinois, 
Indiana, Kansas, Kentucky, Louisiana, Maryland, Michigan, Minnesota, Mississippi, Nevada, 
New York, North Carolina, Ohio, Oklahoma, Oregon, Pennsylvania, South Carolina, Texas, 
Utah, Virginia, and Washington). 
 No influenza activity was reported by 21 states (Alaska, Arkansas, Delaware, Idaho, Iowa, 
Maine, Massachusetts, Missouri, Montana, Nebraska, New Hampshire, New Jersey, New 
Mexico, North Dakota, Rhode Island, South Dakota, Tennessee, Vermont, West Virginia, 
Wisconsin, and Wyoming). 
 
 
 
A description of surveillance methods is available at: http://www.cdc.gov/flu/weekly/overview.htm 
Report prepared: November 5, 2010. 
 
